|
CAPZA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.41800000022607E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.036200E-04 |
| Normal-vs-Stage2 |
3.236800E-01 |
| Normal-vs-Stage3 |
4.53499999775175E-08 |
| Normal-vs-Stage4 |
8.93729534823251E-11 |
| Stage1-vs-Stage2 |
5.865000E-01 |
| Stage1-vs-Stage3 |
6.522000E-03 |
| Stage1-vs-Stage4 |
2.975200E-04 |
| Stage2-vs-Stage3 |
6.071700E-02 |
| Stage2-vs-Stage4 |
2.577900E-02 |
| Stage3-vs-Stage4 |
5.733600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.47800000413778E-08 |
| Normal-vs-AfricanAmerican |
7.35509999572059E-08 |
| Normal-vs-Asian |
5.512400E-01 |
| Caucasian-vs-AfricanAmerican |
6.147700E-02 |
| Caucasian-vs-Asian |
3.282400E-01 |
| AfricanAmerican-vs-Asian |
2.544600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.48389999998777E-06 |
| Normal-vs-Female |
8.48300000244606E-08 |
| Male-vs-Female |
4.590600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.137600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.8682699999939E-05 |
| Normal-vs-Age(61-80Yrs) |
7.48519999982378E-07 |
| Normal-vs-Age(81-100Yrs) |
1.078200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.483400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.021600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.260800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.769200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.570200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.897000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.859700E-02 |
| Normal-vs-Grade 2 |
1.535040E-03 |
| Normal-vs-Grade 3 |
3.1707003689263E-10 |
| Normal-vs-Grade 4 |
8.35542746102647E-12 |
| Grade 1-vs-Grade 2 |
8.262600E-01 |
| Grade 1-vs-Grade 3 |
2.120400E-01 |
| Grade 1-vs-Grade 4 |
2.028200E-02 |
| Grade 2-vs-Grade 3 |
2.154500E-02 |
| Grade 2-vs-Grade 4 |
6.42199999999482E-05 |
| Grade 3-vs-Grade 4 |
1.134330E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.259800E-03 |
| Normal-vs-ccB subtype |
1.442510E-03 |
| ccA subtype-vs-ccB subtype |
3.122000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.170400E-04 |
| Normal-vs-N1 |
1.959200E-01 |
| N0-vs-N1 |
8.033800E-01 |
|
|
